Plenary Sessions-18/04/2020

Saturday, April 18th, 2020

8:30 – 10:45

Plenary session 3: Hematological malignancies

Chairs: H Ten Cate (The Netherlands), F Rodeghiero (Italy)

PL10 - Risk-assessment of thrombosis and bleeding in hematological malignancies
B Brenner (Israel)

PL11 - Advances in management of coagulopathy in APL
MA Sanz (Spain)

PL12 - Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia
A Leader (Israel)

PL13 - Multiple myeloma-associated VTE risk prediction
K Sanfilippo (USA)

Selected Abstract

10:45 - 11:15

Coffee Break

11:15 – 12:15

Plenary Lecture: 6th Simon Karpatkin Memorial Lecture

Chairs: Anna Falanga (Italy); Benjamin Brenner (Israel); Alok A Khorana (USA)

Introduction to Lecture
FR Rickles (USA)

Prediction of VTE in cancer: past, present and future
I Pabinger (Austria)
 

12:15 – 13:30

Roundtable: Emerging practical guidelines for the prevention and treatment of CAT

Chairs: K Syrigos (Greece), R Labianca (Italy)

Introduction: Overview of VTE treatment and prevention in cancer according to clinical guidelines
G Lyman (USA)

Discussant: I Elalamy (France), A Falanga (Italy), TBA

13:30 - 14:30

Lunch Sessions

14:30 - 16:30

Poster Sessions with coffee and pastries

16:30 – 18:15

Plenary Session 4: Prevention of VTE in cancer patients

Chairs: Paolo Prandoni (Italy), TBA

PL14 - Inpatient prophylaxis-where are the data?
J Zwicker (USA)

PL15 - Roles of LMWH for prevention in cancer patients
A Maraveyas (UK)

PL16 - Meta-analysis and systematic review of NOAC prophylaxis in high risk cancer outpatients
N Kuderer (USA) 

Selected Abstract 

18:15 – 19:15

Debate: Outpatient prophylaxis: are we there yet?

Chairs: G Agnelli (Italy), TBA

NO: H Buller (The Netherlands)

YES: AA Khorana (USA)